Cargando…

Linked CD4(+)/CD8(+) T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

Therapeutic benefit to immune checkpoint blockade (ICB) is currently limited to the subset of cancers thought to possess a sufficient tumor mutational burden (TMB) to allow for the spontaneous recognition of neoantigens (NeoAg) by autologous T cells. We explored whether the response to ICB of an agg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolina, Joseph S., Lee, Joey, Brightman, Spencer E., McArdle, Sara, Hall, Samantha M., Thota, Rukman R., Zavala, Karla S., Lanka, Manasa, Ramamoorthy Premlal, Ashmitaa Logandha, Greenbaum, Jason A., Cohen, Ezra E. W., Peters, Bjoern, Schoenberger, Stephen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471175/ https://www.ncbi.nlm.nih.gov/pubmed/37655661 http://dx.doi.org/10.1172/JCI164258

Ejemplares similares

Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023)

Author Correction: Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023)

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4(+) T cells
por: Brightman, Spencer E., et al.
Publicado: (2023)

Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018)

Developmentally distinct CD4(+) T(reg) lineages shape the CD8(+) T cell response to acute Listeria infection
por: Dolina, Joseph S., et al.
Publicado: (2022)

T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls
por: Dhanwani, Rekha, et al.
Publicado: (2020)

Corrigendum: T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls
por: Dhanwani, Rekha, et al.
Publicado: (2021)

Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure
por: Murray, Mallory Paynich, et al.
Publicado: (2021)

TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4(+) T Cells to T(reg)
por: Dolina, Joseph S., et al.
Publicado: (2020)

Computational Prediction and Validation of Tumor-Associated Neoantigens
por: Roudko, Vladimir, et al.
Publicado: (2020)

Both CD8 and CD4 T cells contribute to immunosurveillance preventing the development of neoantigen-expressing autochthonous sarcomas
por: Himes, Jonathon E., et al.
Publicado: (2023)

Identification of patient-specific CD4(+) and CD8(+) T cell neoantigens through HLA-unbiased genetic screens
por: Cattaneo, Chiara M., et al.
Publicado: (2023)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
por: van den Bulk, Jitske, et al.
Publicado: (2023)

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8(+) T cells
por: Fehlings, M., et al.
Publicado: (2017)

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019)

Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4(+) T Cell-Independent CD8(+) T-Cell Response Against Unconjugated Protein Antigen
por: Chiodetti, Ana L., et al.
Publicado: (2018)

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
por: Shankara Narayanan, Jayanth S, et al.
Publicado: (2023)

Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017)

CD8(+) T Cell Exhaustion in Cancer
por: Dolina, Joseph S., et al.
Publicado: (2021)

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4(+) and CD8(+) neoantigen-specific T cells to promote antitumor immunity
por: Hernandez, Rosmely, et al.
Publicado: (2021)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

Neoantigen-specific CD4(+) T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy
por: Peng, Peng, et al.
Publicado: (2020)

Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen
por: Lopez-Bujanda, Zoila A., et al.
Publicado: (2020)

Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
por: Schmidt, Julien, et al.
Publicado: (2023)

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
por: Wang, Yumeng, et al.
Publicado: (2022)

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39(+)CD8(+) T cells
por: Liu, Ting, et al.
Publicado: (2021)

Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8(+) T cells
por: Fehlings, M., et al.
Publicado: (2018)

Intravenous Nanoparticle Vaccination Generates Stem-Like TCF1(+) Neoantigen-Specific CD8(+) T Cells
por: Baharom, Faezzah, et al.
Publicado: (2020)

Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens
por: Buckley, Paul R, et al.
Publicado: (2022)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
por: Xu, Lijun, et al.
Publicado: (2022)

Overcoming CD4 deficiency to induce long-lived memory CD8(+ )CTL
por: Oh, SangKon, et al.
Publicado: (2006)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Polyfunctional CD4(+) T Cell Responses to Immunodominant Epitopes Correlate with Disease Activity of Virulent Salmonella
por: Maybeno, Matt, et al.
Publicado: (2012)

Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20–opsonized B cells to neutrophil killing
por: van Rees, Dieke J., et al.
Publicado: (2022)

CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
por: Zhang, Yuhan, et al.
Publicado: (2023)

Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models
por: Chen, Hengkai, et al.
Publicado: (2022)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests
por: Chatani, Praveen D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bspch604htorqfgt9p2hdqb2g4